MarketPeel
Insider Trading Intelligence
JL

Jay R. Luly

ENTA
PRESIDENT AND CEO · ENANTA PHARMACEUTICALS INC · CIK 0001571211
FILING MIX · LIFETIME48%/52%
BUYS
29
SELLS
31
TOTAL VALUE
$8.11M
COMPANIES
1
ACTIVE SINCE
Dec 2019
HOLDINGS NOW
871,871
AVG SELL PX
$39.29
TRADE KIND
SHOWING 60 / 60
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
11 backtested trades · 8 horizons · 4 pending
Forward-return performance of every backtestable P/S trade by Jay R. Luly, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d11+63.64%-0.54%+0.69%-1.22%-5.83%
14d11+63.64%-1.13%+0.57%-1.70%-1.64%
30d11+54.55%+1.02%+2.30%-1.27%+9.47%
60d11+45.45%-7.12%+4.32%-11.44%-5.49%
90d11+72.73%-7.83%+5.18%-13.01%-7.63%
180d11+81.82%-30.58%+10.75%-42.63%-62.03%
1y11(1 pending)+90.00%-23.39%+23.14%-46.53%-103.72%
2y11(3 pending)+87.50%-67.42%+48.67%-116.09%-132.99%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ENTA · 871,871 shares · as of Feb 12, 2026
0219,507439,013658,520878,0262020202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2019
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
FLOW · 29 buys / 31 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
15,200878,026Feb 12, 2026Feb 13, 2026View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
4,800862,826Feb 12, 2026Feb 13, 2026View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
6,155$14.25$87.7K871,871Feb 12, 2026Feb 13, 2026View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
4,743$14.23$67.5K858,026Dec 5, 2025Dec 5, 2025View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
1,885$14.12$26.6K862,769Dec 1, 2025Dec 3, 2025View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
310,000310,000Nov 25, 2025Nov 26, 2025View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASE
President and CEO
45,000$5.69$256.1K846,638Feb 12, 2025Feb 12, 2025View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
7,484$5.59$41.8K864,654Feb 12, 2025Feb 14, 2025View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
25,500872,138Feb 12, 2025Feb 14, 2025View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE10b5-1
10b5-1 plan
5,142$8.06$41.4K801,638Dec 6, 2024Dec 10, 2024View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
3,829$8.60$32.9K806,780Dec 1, 2024Dec 3, 2024View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
250,000250,000Nov 27, 2024Nov 27, 2024View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,400812,193Feb 12, 2024Feb 14, 2024View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
1,584$12.41$19.7K810,609Feb 12, 2024Feb 14, 2024View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
7,230$9.63$69.6K806,793Dec 5, 2023Dec 6, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
5,787$9.49$54.9K814,023Dec 1, 2023Dec 5, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
264,000264,000Nov 22, 2023Nov 22, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
15,649$45.31$709.1K821,376Mar 13, 2023Mar 14, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
1,566$46.13$72.2K819,810Mar 13, 2023Mar 14, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
27,9120Mar 13, 2023Mar 14, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASE
President and CEO
27,912$14.00$390.8K847,722Mar 13, 2023Mar 14, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
10,697$44.81$479.3K837,025Mar 13, 2023Mar 14, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
20,591$52.77$1.09M819,810Feb 13, 2023Feb 15, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
16,220819,810Feb 13, 2023Feb 15, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
15,285803,590Feb 13, 2023Feb 15, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
20,591$52.77$1.09M799,219Feb 13, 2023Feb 15, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
22,950811,255Feb 13, 2023Feb 15, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
29,146840,401Feb 13, 2023Feb 15, 2023View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASE
President and CEO
14,500$27.58$399.9K788,305Dec 19, 2022Dec 19, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
14,50055,500Dec 19, 2022Dec 19, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
7,800$43.59$340.0K796,005Dec 16, 2022Dec 16, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
13,85127,912Dec 16, 2022Dec 16, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASE
President and CEO
13,851$14.00$193.9K803,805Dec 16, 2022Dec 16, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
8,597$44.54$382.9K787,408Dec 16, 2022Dec 16, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASE
President and CEO
16,149$14.18$229.0K789,954Dec 16, 2022Dec 16, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
13,603$45.49$618.8K773,805Dec 16, 2022Dec 16, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
16,1490Dec 16, 2022Dec 16, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
5,659$44.33$250.9K773,805Dec 1, 2022Dec 5, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
134,000134,000Nov 23, 2022Nov 28, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
63,000779,464Nov 23, 2022Nov 28, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,627712,418Feb 14, 2022Feb 15, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
6,401718,819Feb 14, 2022Feb 15, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
2,355$62.49$147.2K716,464Feb 14, 2022Feb 15, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
10,0630Jan 15, 2022Jan 18, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASE
President and CEO
10,063$11.77$118.4K710,791Jan 15, 2022Jan 18, 2022View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
1,944$87.68$170.4K700,728Dec 1, 2021Dec 3, 2021View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
25,700702,672Nov 19, 2021Nov 23, 2021View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
107,800107,800Nov 19, 2021Nov 23, 2021View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
4,516$59.06$266.7K676,972Sep 15, 2021Sep 17, 2021View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
7,5000Dec 15, 2020Dec 16, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASE
President and CEO
7,500683,689Dec 15, 2020Dec 16, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
2,201$42.52$93.6K681,488Dec 15, 2020Dec 16, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
107,800107,800Nov 20, 2020Nov 20, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
26,500676,189Nov 20, 2020Nov 20, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
1,485643,901Feb 12, 2020Feb 14, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
8,910652,811Feb 12, 2020Feb 14, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
3,122$52.76$164.7K649,689Feb 12, 2020Feb 14, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
PURCHASE
President and CEO
7,500645,746Dec 16, 2019Jan 6, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
7,5007,500Dec 16, 2019Jan 6, 2020View →
ENTA
ENANTA PHARMACEUTICALS INC
SALE
President and CEO
3,330$63.88$212.7K642,416Dec 16, 2019Jan 6, 2020View →
Other insiders · ENTA
Loading peer insiders…
About this filer
CIK 0001571211
ROLE
President and CEO
PRIMARY
ENTA
COMPANIES
1
ACTIVE SINCE
Dec 2019
MARKETPEEL · /INSIDER/0001571211DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback